Quarterly Results

BALAXI PHARMACEUTICALS LTD.

NSE : BALAXIBSE : ISIN CODE : INE618N01014Industry : TradingHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( )0 0
NSE578.358.55 (+1.5 %)
PREV CLOSE( ) 569.80
OPEN PRICE ( ) 569.95
BID PRICE (QTY) 578.35 (50)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11612
TODAY'S LOW / HIGH( ) 569.95 587.25
52 WK LOW / HIGH ( )399.95 686.3
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
Audited
Audited
UnAudited
UnAudited
Net Sales
607.85
547.21
659.55
806.81
Total Expenditure
471.25
439.57
571.14
679.39
PBIDT (Excl OI)
136.6
107.64
88.41
127.42
Other Income
-1.32
2.8
-10.08
-2.2
Operating Profit
135.28
110.44
78.33
125.22
Interest
4.15
3.68
2.9
2.67
Exceptional Items
16.41
56.46
-466.69
NA
PBDT
147.54
163.22
-391.26
122.55
Depreciation
4.81
6.61
2.85
11.88
Profit Before Tax
142.73
156.61
-394.11
110.67
Tax
6.79
12.32
19.31
29.69
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
135.94
144.29
-413.42
80.98
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
135.94
144.29
-413.42
80.98
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
135.94
144.29
-413.43
81
Equity Capital
102.3
102.3
102.3
101.81
Face Value (IN RS)
10
10
10
10
Reserves
NA
NA
NA
NA
Calculated EPS
13.28
14.10
-40.41
7.95
Calculated EPS (Annualised)
53.15
56.41
-161.65
31.82
No of Public Share Holdings
2943846
2943846
2943846
2894896
% of Public Share Holdings
28.78
28.78
28.78
28.43
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
22.47
19.67
13.40
15.79
PBIDTM%
22.25
20.18
11.87
15.52
PBDTM%
24.27
29.82
-59.32
15.18
PBTM%
23.48
28.61
-59.75
13.71
PATM%
22.36
26.36
-62.68
10.03
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.